Konstantinos Farsalinos | 9 May 2014
A study to be published in Nicotine and Tobacco Research was featured in the New York Times and has generated a lot of interest. The article mentioned that e-cigarette vapor can be the source of carcinogens, depending on the heating process. The article is true and expected. We know that thermal degradation can lead to the release of toxic chemicals. And we know that formaldehyde, acetaldehyde and acrolein have been found in vapor. There is nothing new to it. However, this study found that levels may approach those present in tobacco cigarettes. Of course there are some inaccuracies in the NYT article, such as that nicotine gets overheated (which means nothing).
Nicotine Science & Policy | 28 April 2014
The US Food and Drug Administration has published the long awaited proposed ‘deeming’ regulations for e-cigarettes. The major points are that products will need to be registered with the FDA and report product and ingredient listings; that new products can only be marketed after review by the FDA, that companies can only make a claim for reduced risk if the FDA confirms this on the basis of scientific evidence and that the sale of the product will benefit public health. There will be minimum age requirements and restrictions on sales to youth, and a health warning requirement. The FDA has launched a consultation process, with a deadline of July 9th.
Nicotine Science & Policy | 28 April 2014
Data released today (28th April) show over 2 million people in Britain now regularly use electronic cigarettes. This is a threefold rise in just two years: from an estimated 700,000 users in 2012 to around 2.1 million in 2014.
Joe Gitchell | 24 April 2014
The place of “tobacco harm reduction” in the panoply of public health responses to the cigarette smoking epidemic has a long and generally discouraging history (e.g., filters, “low-tar”, “heat not burn”), but given the substantial and increasing toll from cigarette smoking, and the apparent inability of established policies and programs to arrest these trends, the debate about harm reduction will continue. Below I attempt to inventory, in my mind, the primary foundations of why many in the tobacco control community are so skeptical and concerned about the increasing adoption of electronic cigarettes. I claim no monopoly on insight in to this question and certainly welcome the input and comments from others.
Gerry Stimson 29 | March 2014
The fast moving world of e-cigarettes means that it is hard to track the dynamics of this changing scene. There is a lack of good information on the size of the vaping population, trends in the sales of e-cigarettes, and what devices vapers are using. Academic and survey research on the size and characteristics of the vaping population is still minimal, and a picture of what is happening needs to be pieced together from various sources of information including sales and market data.
Nicotine Science & Policy | 24 March 2013
Shaping the discussions at the Global Forum on Nicotine will be presentations from the world’s leading nicotine scientists, researchers and policy analysts.
The science and understanding of nicotine is rapidly changing. The arrival of new nicotine delivery systems, along with other lower risk alternatives to smoking, is forcing rapid changes in nicotine science, public understanding, and the regulatory landscape.
Nicotine Science & Policy | 5 March 2013
Readers of NSP will be well aware that electronic cigarettes are a major disruption for the tobacco industry, governments and regulators, public health and tobacco control organisations, consumers, and the public view of nicotine. Writing in The Times Matt Ridley outlines the risks to individual and public health from excessive regulation that threatens to ‘throttle’ the electronic cigarette industry. Viscount Matt Ridley is one of the few people to have spoken on electronic cigarettes in the UK House of Lords, which we published here.
Nicotine Science & Policy | 23 February 2013
The last few years has seen rapid transformations in the science and understanding of nicotine. The arrival of new nicotine delivery systems, along with other lower risk alternatives to smoking such as snus, is leading to changes in nicotine science, public understanding, and the regulatory landscape. This impacts upon on a wide range of stakeholders.
Lars M. Ramström | 15 February 2014
The ‘WHO Global Report: Mortality Attributable to Tobacco’ has provided estimates of death rates specifically attributable to tobacco. These estimates directly represent the size of each country’s health burden of tobacco, overall and with respect to the different diseases. The current study has extracted data for all European Union Member States and made inter-country comparisons for different age groups and diseases. In these comparisons men in Sweden stand out by exhibiting lower death rates attributable to tobacco than men in any other EU country.
Grzegorz Krol | 7 February 2014
New research presented by Jamie Brown and colleagues at the Society for Research on Nicotine and Tobacco conference, 20th Annual Meeting, held in Seattle on Saturday, February 8, 2014 shows that smokers wishing to quit who used electronic-cigarettes had best outcomes.